CORSAIR CAPITAL MANAGEMENT, L.P.

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1276470 NEW YORK, NY

Position in IOVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,228,500

+$409,500 QoQ

Shares Held

350,000

+16.7% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CORSAIR CAPITAL MANAGEMENT, L.P. holds $2,088,800 across 4 Biotechnology names. IOVA ranks #1 (58.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc. This page	350,000	$1,228,500
2	HALO	Halozyme Therapeutics, Inc.	10,000	$646,300
3	MAIA	MAIA Biotechnology, Inc.	100,000	$140,000
4	NRXS	Neuraxis, INC	10,000	$74,000

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,228,500	350,000	+16.7%	Shares	Sole	2026-05-15
2025-12-31	$819,000	300,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.